《Lancet Respiratory Medicine》重点专注发布RESPIRATORY SYSTEM-RESPIRATORY SYSTEM领域的新研究，旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。根据网友分享的投稿经验，平均审稿速度为 。该杂志创刊至今，在RESPIRATORY SYSTEM-RESPIRATORY SYSTEM领域，影响力非凡，对来稿文章质量要求很高，稿件投稿过审难度很大，刊登文章的学术水平和编辑质量在同类杂志中均名列前茅。如果你想在该杂志上发表论文，你可以向编辑部提交文章，但文章必须具有重要意义并代表该领域专业的发展。我们欢迎广大同领域的研究者提交投稿。
| CiteScore | SJR | SNIP | CiteScore排名 | |||
|---|---|---|---|---|---|---|
| 87.1 | 7.965 | 8.252 | 学科类别 | 分区 | 排名 | 百分位 |
|
大类：大类：Medicine
小类：小类：PulmonaryandRespiratoryMedicine
|
Q1 | 1/155 | 99% | |||
| 按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：CRITICAL CARE MEDICINE | SCIE | Q1 | 1 / 54 | 99.1% |
| 学科：RESPIRATORY SYSTEM | SCIE | Q1 | 1 / 100 | 99.5% |
| 按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：CRITICAL CARE MEDICINE | SCIE | Q1 | 1 / 55 | 99.09% |
| 学科：RESPIRATORY SYSTEM | SCIE | Q1 | 1 / 101 | 99.5% |
文章名称
引用次数
Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis
176
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial
152
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper
110
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study
104
Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial
103
The global burden of paediatric and neonatal sepsis: a systematic review
71
Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial
70
Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life
64
Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials
62
The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era
60
国家/地区
发文量
TUSA
286
TEngland
230
TCanada
86
TGERMANY (FED REP GER)
84
TFrance
79
TNetherlands
74
TItaly
72
TAustralia
69
TSpain
51
TSouth Africa
46
